Stock Events

Stock Events

Orion 

€70.95
136
+€1.05+1.5% Today

Statistics

Day High
71.2
Day Low
69.95
52W High
74.95
52W Low
54.6
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
2.57%
Dividend
1.83

Upcoming

19
OCT
Dividend Ex
 
27
OCT
Dividend Payment
 
25
MAR 27
Dividend Ex
Estimated
 
2
APR 27
Dividend Payment
Estimated
 

Dividends

2.57%Dividend Yield
Apr 26
€0.9
Oct 25
€0.82
Apr 25
€0.82
Oct 24
€0.81
Apr 24
€0.81
10Y Growth
3.31%
5Y Growth
3.71%
3Y Growth
4%
1Y Growth
9.76%

Earnings

17JulExpected
Q4 2025
Next
Next
-0.29
0.12
0.53
0.94
Expected EPS
0.9359228163693087
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow OFK.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novo Nordisk
NVO
Mkt Cap194.57B
Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This competes directly with Orion's pharmaceutical products, especially in the diabetes and hormone replacement sectors.
Pfizer
PFE
Mkt Cap149.77B
Pfizer is a global pharmaceutical corporation which competes across various therapeutic areas including oncology, neurology, and immunology, overlapping with Orion's product portfolio.
Merck
MRK
Mkt Cap277.02B
Merck & Co., Inc. is known for its contributions to pharmaceuticals across a range of conditions, directly competing with Orion in areas like cancer and neurodegenerative diseases.
Astrazeneca
AZN
Mkt Cap286.4B
AstraZeneca operates in key areas such as oncology, cardiovascular, renal & metabolism, and respiratory & immunology, which are also focus areas for Orion, making them direct competitors.
GSK
GSK
Mkt Cap103.01B
GlaxoSmithKline is a global healthcare company that researches and develops a broad range of innovative products in pharmaceuticals, vaccines, and consumer healthcare, competing with Orion especially in the respiratory and CNS sectors.
Rogers
ROG
Mkt Cap2.4B
Roche Holding AG is a pioneer in healthcare, leading in cancer treatments and diagnostics, directly competing with Orion's oncology and diagnostic products.
Novartis
NVS
Mkt Cap279.67B
Novartis is one of the largest pharmaceutical companies by both market cap and sales, competing in areas like oncology, neurology, and immunology, similar to Orion.
Sanofi
SNY
Mkt Cap110.4B
Sanofi focuses on pharmaceuticals and human vaccines, with a strong presence in diabetes, oncology, and rare diseases, areas that Orion also operates in.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap40.7B
Teva Pharmaceutical Industries Ltd. is a global leader in generic and specialty medicines, competing with Orion in the provision of generic drugs and active pharmaceutical ingredients.

About

There is no Profile data available for OFK.MU.
Show more...
CEO
Country
Germany
ISIN
FI0009014377

Listings

STU
DE
OFK.STU
MU
DE
0OE.MU
MU
DE
OFK.MU
LSE
GB
0M2N.LSE

0 Comments

Share your thoughts

FAQ

What is Orion stock price today?▼
The current price of OFK.STU is €70.95 EUR — it has increased by +1.5% in the past 24 hours. Watch Orion stock price performance more closely on the chart.
What is Orion stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Orion stocks are traded under the ticker OFK.STU.
Is Orion stock price growing?▼
OFK.STU stock has risen by +8.14% compared to the previous week, the month change is a -0.97% fall, over the last year Orion has showed a +26.85% increase.
When is the next Orion earnings date?▼
Orion is going to release the next earnings report on July 17, 2026.
Does Orion pay dividends?▼
Yes, OFK.STU dividends are paid semi-annual. The last dividend per share was 0.9 EUR. As of today, Dividend Yield (FWD)% is 2.57%.
In which sector is Orion located?▼
Orion operates in the Other sector.
When did Orion complete a stock split?▼
Orion has not had any recent stock splits.